342 related articles for article (PubMed ID: 29035368)
1. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
[TBL] [Abstract][Full Text] [Related]
2. New role for ceramide in hypoxia and insulin resistance.
Xia QS; Lu FE; Wu F; Huang ZY; Dong H; Xu LJ; Gong J
World J Gastroenterol; 2020 May; 26(18):2177-2186. PubMed ID: 32476784
[TBL] [Abstract][Full Text] [Related]
3. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
4. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis.
Zhou LY; Zeng H; Wang S; Chen JX
Cell Physiol Biochem; 2018; 48(3):1003-1011. PubMed ID: 30036883
[TBL] [Abstract][Full Text] [Related]
6. Modulation of HIF-2α PAS-B domain contributes to physiological responses.
Feng Z; Zou X; Chen Y; Wang H; Duan Y; Bruick RK
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13240-13245. PubMed ID: 30523118
[TBL] [Abstract][Full Text] [Related]
7. Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.
Das N; Xie L; Ramakrishnan SK; Campbell A; Rivella S; Shah YM
J Biol Chem; 2015 Sep; 290(39):23523-7. PubMed ID: 26296885
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism.
Zhang X; Zhang Y; Wang P; Zhang SY; Dong Y; Zeng G; Yan Y; Sun L; Wu Q; Liu H; Liu B; Kong W; Wang X; Jiang C
Cell Metab; 2019 Nov; 30(5):937-951.e5. PubMed ID: 31668872
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein.
Morello E; Sutti S; Foglia B; Novo E; Cannito S; Bocca C; Rajsky M; Bruzzì S; Abate ML; Rosso C; Bozzola C; David E; Bugianesi E; Albano E; Parola M
Hepatology; 2018 Jun; 67(6):2196-2214. PubMed ID: 29266399
[TBL] [Abstract][Full Text] [Related]
10. Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells.
Mooli RGR; Mukhi D; Pasupulati AK; Evers SS; Sipula IJ; Jurczak M; Seeley RJ; Shah YM; Ramakrishnan SK
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1057-1072. PubMed ID: 34902628
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
[TBL] [Abstract][Full Text] [Related]
12. Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2α.
Xia QS; Wu F; Wu WB; Dong H; Huang ZY; Xu L; Lu FE; Gong J
Biomed Pharmacother; 2022 Jun; 150():112955. PubMed ID: 35429745
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Autelli R; Novo E; Bocca C; Villano G; Ramavath NN; Younes R; Tusa I; Rovida E; Pontisso P; Bugianesi E; Albano E; Parola M
Cell Mol Gastroenterol Hepatol; 2022; 13(2):459-482. PubMed ID: 34655812
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2α.
Cao R; Zhao X; Li S; Zhou H; Chen W; Ren L; Zhou X; Zhang H; Shi R
Cell Physiol Biochem; 2014; 34(5):1427-41. PubMed ID: 25323790
[TBL] [Abstract][Full Text] [Related]
16. Intestinal MYC modulates obesity-related metabolic dysfunction.
Luo Y; Yang S; Wu X; Takahashi S; Sun L; Cai J; Krausz KW; Guo X; Dias HB; Gavrilova O; Xie C; Jiang C; Liu W; Gonzalez FJ
Nat Metab; 2021 Jul; 3(7):923-939. PubMed ID: 34211180
[TBL] [Abstract][Full Text] [Related]
17. Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis.
Anderson ER; Xue X; Shah YM
J Biol Chem; 2011 Jun; 286(22):19533-40. PubMed ID: 21498508
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
Cai H; Bai Z; Ge RL
Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
[TBL] [Abstract][Full Text] [Related]
19. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.
Choe SS; Shin KC; Ka S; Lee YK; Chun JS; Kim JB
Diabetes; 2014 Oct; 63(10):3359-71. PubMed ID: 24947359
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis.
Qu A; Taylor M; Xue X; Matsubara T; Metzger D; Chambon P; Gonzalez FJ; Shah YM
Hepatology; 2011 Aug; 54(2):472-83. PubMed ID: 21538443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
